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Increased Serum Albuterol Concentrations May Be Associated With Elevations
Of Serum Lactate In Subjects With Acute Asthma Exacerbations
Kristen Aubuchon1, Kazuko Matsuda2, Stacey L. House1, Ian Ferguson1, John Schneider1, Lawrence Lewis1
1Division

of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri; 2Medicinova, Inc., San Diego, CA

BACKGROUND
We have previously described increased serum lactate concentrations in subjects
with acute asthma exacerbations. It is not clear if this is due to increased work of
breathing or a possible side effect of treatment (in particular beta-adrenergic
agonist therapy).

RESULTS
•42 subjects were enrolled to date, 20 with complete data.

RESULTS (cont.)

•The mean baseline serum lactate level was 19.3 mg/dL (SD ±9.5).
increased to 32.6 mg/dL (SD ±15.8) at 1.25 hrs.

This

•The mean 1 hr DS was 3.85+ 2.0.
OBJECTIVES
1) Determine if a significant correlation exists between treatment lactate or ∆
lactate, and serum albuterol concentrations after adjusting for dyspnea score.
2) Determine if elevated treatment lactate concentrations or ∆ lactate
concentrations are associated with increased hospital admissions.

•The correlation between treatment lactate, ∆ lactate, 1 hr serum albuterol
concentrations (R, S and total) and admission to hospital are shown (see table
below). Both treatment and ∆ lactate were highly correlated with total serum
albuterol, R albuterol, and S albuterol.

METHODS
•Interim, subgroup analysis of a prospective, interventional, double-blind, placebo
controlled trial of an IV beta-adrenergic agonist in ED patients with acute asthma
exacerbations.
•FEV1 < 50% predicted 30 minutes following initiation of “standard care” (includes
a minimum of 2.5 mg nebulized albuterol; 0.5 mg nebulized ipratropium; and 50
mg of a corticosteroid). ED physicians, unaware of study objectives, administered
all treatments.
•Subjects were randomized in a 1:1 ratio to either placebo or an investigational
intravenous beta agonist arm. Blood was obtained at 1 and 1.25 hours after the
start of the hour long infusion for determination of albuterol , electrolytes, and
lactate concentrations; and a Modified Borg Dyspnea Score (DS) was calculated
for all patients.
•Treatment lactate and ∆ lactate were correlated with 1 hr serum albuterol
concentrations and hospital admission, using partial Pearson correlations to adjust
for DS.

R Albuterol S Albuterol Total Albuterol Admit
Treatment
Lactate

Delta
Lactata

0.497

0.674

•There was no correlation between treatment lactate or ∆ lactate and hospital
admission. There was also no significant difference in mean lactate levels in
admitted vs. non-admitted subjects (32.8 mg/dL vs. 32.1 mg/dL, p=0.9).
•There was a trend in twenty-four hour DS in patients with markedly elevated
lactate (≥ 30 mg/dL) compared to those with lactate < 30 mg/dL (3.19 vs. 1.88,
p=0.08)

DISCUSSION
Lactic acidosis may be caused by increased production (Type A) or decreased
utilization (metabolism) (Type B). 1 Type B lactic acidosis may be caused by
alcohol or drugs. There have been several reports of increased lactate associated
with beta agonists. 2 A recent study in children treated for acute severe asthma,
showed that the mechanism of lactic acidosis was most often Type B. 3

Correlation
Coefficient

0.505

-0.018

Significance
(2 tailed)

0.028

0.030

0.002

0.910

Correlation
Coefficient

0.519

0.525

0.605

-0.075

Lactate and ∆ lactate concentrations correlate with albuterol concentrations in
patients presenting with acute asthma exacerbations after adjusting for dyspnea
score, but do not correlate with hospital admission.

Significance
(2 tailed)

0.023

0.021

0.006

0.643
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